A neurysmAl subarachnoid hemorrhage (SAH) is a significant cause of morbidity and mortality. The estimated incidence of SAH is 5-10 cases per 100,000 patients per year.
As in adults, the treatment of intracranial aneurysms in children can involve microsurgical clip ligation, wrapping, and endovascular treatment including flow diversion, coiling, and embolization of the aneurysm and parent vessel. 1, 13, 14, 20, 30, 34, 37 The rate of new SAH is higher in both adults and children with a previous aneurysm rupture than in the general population; it occurs as a result of recurrent aneurysms as well as de novo aneurysm formation. 4, 35, 39 In pediatric patients with a mean follow-up of 4-6 years, 11, 15, 30 a 13%-23% cumulative rate of de novo aneurysm formation has been reported. 15, 29, 30 We discuss the case of a 6-month-old girl who initially presented with a ruptured left middle cerebral artery (MCA) aneurysm treated with microsurgical clip ligation who had de novo aneurysm formation and rupture from an adjacent segment just 55 days later and was found to have a mutation in the myosin heavy chain 11, smooth muscle gene (MYH11). We present the imaging and clinical course of this case and review the literature on recurrent spontaneous aneurysm formation and rupture in the pediatric population.
Case report

Initial Presentation
A 6-month-old female with no significant medical history presented to an outside emergency department with a new-onset focal seizure consisting of tonic posturing of the right upper and right lower extremities. Intravenous levetiracetam was administered, and a noncontrast head CT scan demonstrated an SAH centered along the left sylvian fissure with blood extending around the circle of Willis, hypodensity within the left MCA territory, and an acute, thin left subdural hematoma (Fig. 1) .
The patient was transferred via air ambulance to our institution for neurosurgical evaluation and management. On arrival, she was bradycardic and hypertensive. Her anterior fontanelle was full but not tense, and there were no signs of external trauma. Her pupillary examination demonstrated asymmetry; the left pupil was minimally reactive and the right pupil was briskly reactive. Her motor examination demonstrated withdrawal in the left upper and lower extremities with no observable movement in the right upper and lower extremities upon stimulation. Computed tomography angiography (CTA) demonstrated a 7 × 6 × 5-mm saccular aneurysm of the left MCA inferior division of the M 2 segment (Fig. 2) . The patient was admitted to the intensive care unit (ICU), treated with hypertonic saline, and hemodynamically stabilized with strict blood pressure control. She had no family history of bleeding disorders, cerebral aneurysms, or inherited vasculopathy, connective tissue disease, or history of congenital heart disease.
Initial Surgical Management
A multidisciplinary decision was made to treat the ruptured aneurysm via microsurgical clip ligation given the patient's young age, the aneurysm location at the MCA bifurcation, and the technically challenging morphology from an endovascular perspective. A formal angiogram was not obtained because the aneurysm geometry and parent vessel anatomy were well visualized by the CTA, and we did not want to expose the infant to additional diagnostic radiation that would not affect our treatment decision. The patient underwent a left frontotemporal craniotomy and placement of an external ventricular drain (EVD), and the aneurysm was secured with clips after transsylvian dissection of the MCA bifurcation and aneurysm.
Intraoperatively, we initially encountered the subdural hematoma; after evacuation, we noted that the pia along the sylvian fissure was torn parallel to the fissure, communicating the subarachnoid space and acute aneurysmal hemorrhage with the subdural space. After extending this opening and evacuating the hemorrhage within the sylvian fissure, we visualized the aneurysm, and the M 1 segment was dissected. A temporary clip was placed across the M 1 trunk, and the vessel was followed to the aneurysm's neck along the inferior M 2 branch, which appeared circumferentially dysplastic. A large straight titanium clip was initially placed across the aneurysm neck, but micro-Doppler ultrasonography demonstrated no distal flow. The clip was repositioned with restoration of flow, leaving a small bleb of the aneurysm outside the clip. A small curved clip was stacked beneath the straight clip. Because the entire parent vessel appeared dysplastic, it was circumferentially wrapped with muslin gauze. Micro-Doppler ultrasonography demonstrated good distal flow after temporary clip removal.
Initial Postoperative Course
The patient was managed in the pediatric ICU postoperatively. A head CT on postoperative Day 1 (Fig. 3 ) demonstrated an intact clip construct and decompression of the ventricles with the EVD. She underwent cerebral angiography on postoperative Day 5 (postictus Day 6), which visualized the clip construct (Fig. 4A ). Anterior projections ( Fig. 4B and C) demonstrated obliteration of the aneurysm, as well as a small bleb remnant. There was some evidence of delayed filling of the distal M 2 vessels on the left side but no definitive evidence of vasospasm; it probably represented partial occlusion of the vessel distal to the aneurysm clip. Given the patient's improving clinical examination findings, she was monitored with no intervention. The remainder of the cerebrovasculature appeared normal, without evidence of vasculitis or addition- The patient continued to experience seizures in the postoperative period and was monitored with continuous video electroencephalography. Phenobarbital was administered in addition to the levetiracetam, and her seizures resolved. She was weaned from the EVD, which was clamped and eventually removed without hydrocephalus. She was treated with nimodipine (0.75 mg/kg every 4 hours) postoperatively for 17 days without adverse effects. She was transferred from the pediatric ICU after 12 days, weaned from levetiracetam, and discharged 20 days after admission with improving right hemiparesis.
Second Presentation
Fifty-five days after the initial aneurysm rupture, the patient developed recurrent seizure activity with clonic movement of the right upper and lower extremities. Computed tomography scanning of the head without contrast demonstrated a new, acute intraparenchymal hemorrhage of the left anterior temporal lobe into the area of previous ischemia ( Fig. 6 ), without significant mass effect. After the reintroduction of levetiracetam, the patient rapidly returned to her baseline except for a worsening of her right hemiparesis. Computed tomography angiography demonstrated a de novo saccular aneurysm measuring 5 × 4 mm along the superior M 2 branch of the left MCA (Fig. 7) , representing a de novo ruptured aneurysm.
Second Surgical Management and Hospital Course
The patient was once again stabilized in the pediatric ICU, and the next day a cerebral angiogram confirmed de novo aneurysm formation on a different M 2 branch from the initial aneurysm, as well as dysplastic features of the vessel distal to the aneurysm, with 2 additional smaller aneurysms forming (Fig. 8A ). In the context of prior stroke and the short interval between initial aneurysm rupture and de novo aneurysm formation with dysplastic features distal to the de novo lesion, the decision was made to sacrifice the parent vessel, which was successfully achieved with Onyx embolization (Fig. 8) . The patient underwent MRI of the brain the following day, which demonstrated a stable appearance of the hematoma, evolution of the previous stroke, and no new restricted diffusion within the left MCA territory (Fig. 9) . She had an uneventful postoperative course and was discharged home 4 days later with an improving right hemiparesis.
Medical Evaluation
Serological testing did not support a diagnosis of vasculitis (erythrocyte sedimentation rate [ESR] 6, C-reactive protein [CRP] 0.6, antinuclear antibody [ANA] negative), the patient's von Willebrand factor level was normal, and myeloperoxidase and proteinase 3, anti-cardiolipin IgG/ IgM, and b2 glycoprotein IgG/IgM tests were negative.
Coagulation studies demonstrated a normal prothrombin time with slightly elevated partial thromboplastin time, which corrected with a 1:1 mixing study, and a negative lupus anticoagulant assay.
Genetic testing was performed using a 21-gene aortopathy vasculopathy panel array. This revealed a heterozygous mutation of MYH11 on 16p13.11 (c.5273G > A), which encodes the myosin heavy chain 11 protein in smooth muscle. Mutations in MYH11 have been associated with thoracic aortic aneurysms and dissections (TAADs) but never with cerebral aneurysms.
Follow-Up
Three months after her initial aneurysm rupture, the patient was seen in follow-up. She demonstrated additional improvement in her right hemiparesis, no further seizures, and no signs of hydrocephalus. Surveillance imaging with MR angiography (MRA) is planned to screen for new aneurysm formation.
Discussion
We present the case of a 6-month-old infant who initially presented with rupture from a left MCA inferior M 2 branch aneurysm that was managed with microsurgical clip ligation; the patient returned just 55 days later with de novo aneurysm formation and rupture along the superior branch. This subsequent occurrence was treated with Onyx embolization of the aneurysm and the parent vessel. Genetic testing demonstrated that the patient is heterozygous for an MYH11 mutation. This is the first report of rapid de novo aneurysm formation in an infant with an MYH11 mutation.
epidemiology and Natural history
Cerebral aneurysms in children account for 0.5%-4.6% of those in large reported series of intracranial aneurysms, 5, 7, 19, 21, 24, 28, 32 and lesions diagnosed in the first 2 decades of life account for 1%-4% of all intracranial aneurysms. 12, 15, 17, 29 Compared with those in adults, cerebral aneurysms in young children are more often nonsaccular, dissecting, or fusiform. 8 Additionally, they are more com- monly secondary to systemic conditions including infection, inherited vasculopathy, familial connective tissue disease, and congenital heart disease. 3 Pediatric cerebral aneurysms are also more frequently giant, tend to form in the posterior circulation and at the internal carotid artery bifurcation, and have a male preponderance. 19, 26, 30, 33 Fusiform aneurysms are less common in adults, more common in children, 6, 11 and frequently occur along the MCA branches. 6 The featured case represents a rare saccular aneurysm arising from the inferior division of M 2 with de novo saccular aneurysm formation at the superior division of M 2 .
The rapid de novo aneurysm formation in the presented case is concerning but sheds light on cerebral aneurysms as a disease process rather than a single lesion that requires treatment. Despite a number of large series of pediatric cerebral aneurysms, a paucity of literature covers the timing of de novo aneurysm formation, particularly in infants. Stiefel and colleagues 34 documented a series of 12 patients with 13 aneurysms over a 12-year period, including 1 patient with severe Takayasu's arteritis who developed a de novo ruptured aneurysm after 6 months, leading to her death. In contrast, our patient had no evidence of vasculopathy, a rheumatological condition, or a congenital disorder that would put her at risk for rapid formation and rupture of 2 cerebral aneurysms. In a series of 32 patients treated with both open surgical clipping and endovascular coiling, Sanai and colleagues 30 reported on 4 pediatric patients (10-15 years old) with de novo aneurysms separated from initial treatment by 18-180 months, all much longer intervals than in our patient. Table 1 summarizes multiple large series of pediatric cerebral aneurysms and reports of de novo aneurysm formation timing.
Myosin heavy Chain 11
Myosin heavy chain 11 protein is a specific contractile protein of smooth muscle cells. 27 Mutations in MYH11 have been identified in 2 families with autosomal dominant inheritance leading to TAAD in conjunction with patent ductus arteriosus. 40 The hypothesized mechanism is a disturbance in contractile smooth muscle cell function leading to lower aortic compliance and elastolysis with focal vascular smooth muscle hyperplasia. 22 The identification and association of MYH11 mutations with thoracic aortic aneurysms confirms the critical importance of the smooth muscle cell contractile system to maintain the structural integrity of the ascending aorta. 9 Immunohistochemistry staining of aortic biopsy specimens from a patient and family member with an MYH11 also demonstrated upregulation of the transforming growth factor-b (TGF-b) signaling pathway. 27 At the molecular level, patients with TAAD harbor the mutation identified in our patient, which leads to the amino acid alteration of p.Arg1758Gln, together with the IVS32+1G > T allelic variant. Together this mutation and variant results in an in-frame deletion and the loss of exon 32 encoding 71 amino acids. 40 This causes a conformational change in the alpha-helical coiled-coil domain of the smooth muscle myosin heavy chain. That conformational change prevents the protein from assembling into a functional homodimer, leading to a dominant negative effect. 40 Although our patient harbors the same mutation, the IVS32+1G > T allelic variant was not found, so it is unclear if the mutation alone leads to a similar conformational change of the alpha-helical coiled-coil domain. However, the amino acid change caused by the mutation (p.Arg1758Gln) impacts a highly conserved arginine residue in the myosin heavy chain 11 protein, which strongly suggests this mutation may be pathogenic. 2 Although MYH11 mutations are associated with TAAD, an association with cerebral aneurysms has not been reported. The patient featured in this report represents an index case and may shed light on an important molecular pathway that leads to the formation of cerebral aneurysms in children. The mechanism is probably similar to the formation of thoracic aortic aneurysms-namely, progressive decrease in vessel wall compliance with elastolysis eventually leading to rupture.
An additional mutation in smooth muscle cytoskeletal protein actin alpha-2 (ACTA2), which has been associated with moyamoya disease and stroke, 9 was not detected in this case.
long-term surveillance
The long-term surveillance and management of children with cerebral aneurysms presents a distinct challenge. Koroknay-Pál and colleagues 18 reported on the long-term follow-up (median 34 years, range 4-56 years) of a cohort of 59 children who presented with cerebral aneurysms between 1937 and 2009 in Finland. Based on 1935 personyears of follow-up, the annual rate of de novo or recurrent aneurysm formation was 1.9%, with a 0.4% annual rate of hemorrhage. Among patients with a prior SAH (52 [88%] of 59), during 1766 person-years of follow-up, the annual rate of de novo or recurrent aneurysm formation was 2.0%, and the annual hemorrhage rate was 0.5%. One-third of patients developed more than one new aneurysm, but the earliest symptomatic recurrent aneurysm occurred 6 years after treatment. Given these data, the authors recommended that all children diagnosed with intracranial aneurysms should undergo surveillance MRA at 3-to 5-year intervals. Our case suggests that the rate of early aneurysm formation and SAH may be higher and would warrant closer surveillance in this population, especially in the context of a likely pathological MYH11 mutation. In a previous publication, the same investigators reported on 102 children with intracranial aneurysms. 16 In that cohort, 80 patients (78%) survived 1 year after SAH; among them, 8 patients (10%) died of recurrent SAH after a median time of 11 years (range 1.5-33.4 years). The cause of recurrent SAH was de novo aneurysm rupture in 3 patients and recurrent rupture of an incompletely occluded aneurysm in 4 patients (1 patient was lost to follow-up). The investigators concluded that, over the long term, there are high rates of excess mortality due to recurrent aneurysms and hemorrhage in children who present with intracranial aneurysms. The case we present is unusual because of the rapid de novo aneurysm formation; therefore, the patient will require long-term radiographic surveillance. In addition to the known risk factors for aneurysm growth and rupture in adults-smoking, hypertension, and excessive alcohol use-the patient has a high risk of de novo aneurysm formation, intracranial hemorrhage, and neurological morbidity from progressive cerebrovascular disease.
treatment
The treatment options for cerebral aneurysms in children are similar to those used in adults, including microsurgical clip ligation and endovascular occlusion. Stiefel and colleagues 34 suggested that microsurgical clipping should be the standard first-line treatment for all aneurysms, except when surgery is not a viable option or for lesions at Specifically, liquid embolization, coil embolization, and flow diversion represent new frontiers in the treatment of pediatric cerebral aneurysms, and their use should be considered carefully. 31 In the featured case, microsurgical clip ligation was used to treat the initial MCA aneurysm, which was not considered amenable to endovascular occlusion given its geometry, its MCA location, and the patient's age. 36 The de novo aneurysm was embolized using Onyx liquid embolization (Covidien), and the parent vessel was sacrificed because of the dysplastic appearance of the distal vessel and the potential of future aneurysms to form along this segment (Fig. 8C) . Onyx is routinely used as an off-label liquid embolic for vessel occlusions for persistent epistaxis, pseudoaneurysm occlusion, and tumor embolizations. Onyx offers the best embolic agent characteristics, since it allows for complete occlusion of the aneurysm itself as well as the ability to push the material more distally for occlusion of the residual dysplastic vessel.
Although our patient did not experience significant angiographic vasospasm, this additional element should be considered when discussing de novo aneurysm formation and management of infants with SAH. Other reports have commonly observed angiographic vasospasm in children who present with aneurysm rupture but have rarely noted its clinical significance. 10, 13, 19, 21, 23, 26, 38 In children younger than 2 years of age, however, vasospasm can be severe, possibly leading to debilitating large-vessel strokes, 34 probably due to high blood vessel reactivity. Reports on the use of nimodipine to reduce the risk of deficit from clinical vasospasm in children with aneurysmal SAH are limited, although its use in adults has been evaluated in the literature. 25 We safely used nimodipine in the treatment of our patient, suggesting that it is feasible, but the long-term benefit is unknown.
Conclusions
We present the rare case of a 6-month-old girl who initially presented with a ruptured left MCA aneurysm and returned only 55 days after her initial ictus with de novo aneurysm rupture from an adjacent M 2 segment. She was found to be heterozygous for an MYH11 mutation associated with alterations in vascular smooth muscle structure. To our knowledge, this is the first report of rapid de novo cerebral aneurysm formation in an infant with an MYH11 mutation. Comprehensive review of the literature stresses a high risk of recurrent aneurysm formation and intracranial hemorrhage. Careful imaging surveillance and clinical follow-up is critical to minimize neurological morbidity, especially in infants who present with aneurysm rupture. This case helps us begin to elucidate the long-term effects and consequences of this disease process. Further study of the contribution and impact of the MYH11 mutation is necessary.
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